Better Buy: AbbVie vs. Johnson & Johnson - The Motley Fool

Better Buy: AbbVie vs. Johnson & Johnson  The Motley Fool

AbbVie (NYSE:ABBV) and Johnson & Johnson (NYSE:JNJ) partner on one of the biggest cancer drugs in the world. At the same time, the two pharmaceutical ...